BioLineRx (BLRX) Interest Expenses (2011 - 2026)
BioLineRx's Interest Expenses came in at -$208,000 for the quarter ended Jun 30, 2026, compared with -$276,000 a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Interest Expenses (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioLineRx reported Interest Expenses of -$1.04 million; for the year ended Dec 31, 2025, it was -$1.28 million.
- Going back by year, Interest Expenses was -$9.12 million in the year ended Dec 31, 2024, -$2.17 million in the year ended Dec 31, 2023, -$2.16 million in the year ended Dec 31, 2022 and -$1.01 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Interest Expenses since the quarter ended Dec 31, 2023.
- Business Quant data shows BLRX's Interest Expenses at -$250,000 (quarter ended Mar 31, 2026), -$280,000 (quarter ended Dec 31, 2025) and -$304,000 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | BioLineRx | 6.16 Bn | 6.16 Bn | 235,000.00 | -208,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -208,000.00 |
| Mar 31, 2026 | -250,000.00 |
| Dec 31, 2025 | -280,000.00 |
| Sep 30, 2025 | -304,000.00 |
| Jun 30, 2025 | -276,000.00 |
| Mar 31, 2025 | -420,000.00 |
| Dec 31, 2024 | -4.48 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.09 Mn |
| Mar 31, 2024 | -929,000.00 |
| Dec 31, 2023 | 932,000.00 |
| Sep 30, 2023 | -837,000.00 |
| Jun 30, 2023 | -1.34 Mn |
| Mar 31, 2023 | -927,000.00 |
| Dec 31, 2022 | -1.33 Mn |
| Sep 30, 2022 | -267,000.00 |
| Jun 30, 2022 | -379,000.00 |
| Mar 31, 2022 | -186,000.00 |
| Dec 31, 2021 | -204,000.00 |
| Sep 30, 2021 | -261,000.00 |
API Access
BioLineRx Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();